Jazz Pharmaceuticals JAZZ Intangible assets — net
Intangible assets — net at other companies
Other financials
Where this comes from
Reported directly by Jazz Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:FiniteLivedIntangibleAssetsNet.
The official record: Jazz Pharmaceuticals’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Jazz Pharmaceuticals's intangible assets — net.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Jazz Pharmaceuticals's intangible assets — net?
- Jazz Pharmaceuticals (JAZZ) reported intangible assets — net of $4.2B in Q1 2026.
- How has Jazz Pharmaceuticals's intangible assets — net changed year-over-year?
- Jazz Pharmaceuticals's intangible assets — net decreased by 10.9% year-over-year, from $4.72B to $4.2B.
- What is the long-term trend for Jazz Pharmaceuticals's intangible assets — net?
- Over 5 years (2020 to 2025), Jazz Pharmaceuticals's intangible assets — net has grown at a 15.1% compound annual growth rate (CAGR), from $2.2B to $4.43B.